Osteosarcoma: MIB Agents Osteosarcoma Alliance
Your Community in the Fight Against Osteosarcoma.
MIB Agents is a leading pediatric osteosarcoma nonprofit, passionately dedicated to Making It Better (MIB). We connect patients, caregivers, and experts to accelerate osteosarcoma research, discover better treatments, and advance closer to a cure for this bone cancer. Join our mission to Make It Better!
#cancerawareness #osteosarcoma #cancersupport #mibagents #podcast #webinar #cancer #childhoodcancer #pediatriccancer
osTEAo: преодоление потерь в сообществе AYA
OsteoBites: Синергия ингибиторов ATM и PARP при детской остеосаркоме
OsteoBites | Comparative extracellular vesicle EV biomarkers for osteosarcoma risk and prognosis
osTEAo AYA Podcast: Spooky Sarcoma Stories
OsteoBites: идеи и инновации AACR в области исследований детской онкологии
OsteoBites: исследование саркомы доматиностата/сиролимуса (рецидивирующая/рефрактерная фаза 1/2)
osTEAo AYA Podcast | Turning Pain Into Purpose
Osteobites: Chromosomal Instability and Osteosarcoma Patient Outcomes
How To Assemble Your Gold Bow
Osteobites | Deciphering the impact of STING agonists on the tumor microenvironment in osteosarcoma
Factor 2025 Recap
MIB Agents Healing Hearts Bereavement Program
MIB Agents NextGen
osTEAo | The Fault in Our Scars - Dating & Cancer
Outsmarting Osteosarcoma 2026: Research Grant Application Guide and Overview
OsteoBites: Clinical biomarkers for osteosarcoma stratification cBOSS Insights from a working group
OsteoBites: Simultaneous targeting of CDK4 6 and BETs is independent of RB status in osteosarcoma
FACTOR 2025 Collaborative Data Ecosystems Panel
osTEAo AYA Podcast | When Positivity Silences Pain
Osteobites: Old drugs, new tricks A novel immunomodulatory approach to relapsed osteosarcoma therapy
FACTOR 2025 Mechanisms of Resistance and Evolution Panel
FACTOR 2025: Tumor Heterogeneity and Microenvironment Interactions Panel
OutSmarting Osteosarcoma 2025 Award Presentations
FACTOR 2025: Biological Drivers of Osteosarcoma Panel
Award Presentation to Alex Davies, DVM, PhD in partnership with Fishin' for the Cure
FACTOR 2025: Clinical Trials Panel
FACTOR 2025 Precision Medicine Panel
FACTOR 2025: Closing Keynote